National Institute of Health
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1887-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://heal.nih.gov
Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
News
CanSino Biologics Launches Phase 3 COVID-19 Vaccine Trial in Pakistan Despite Declining Case Numbers
CanSino Biologics' Ad5-nCoV COVID-19 vaccine candidate is set to begin Phase 3 clinical trials in Pakistan in September 2020, marking the country's first Phase 3 vaccine trial.
St. Joseph's/Candler Pioneers Novel Dosing Study for Metastatic Breast Cancer Treatment
• St. Joseph's/Candler launches groundbreaking clinical trial across three locations to investigate optimized dosing strategies for CDK4/6 inhibitors in metastatic breast cancer treatment. • The study compares titrated dosing approach starting with lower doses versus standard dosing with reductions, aiming to enhance treatment outcomes and patient quality of life. • Led by Dr. Leonard Henry, the trial represents a significant advancement in local cancer care, making cutting-edge research accessible to patients in the Coastal Empire and Lowcountry regions.
Reconditioned Pacemakers Show Similar Performance to New Devices in Clinical Trial
A randomized trial revealed that reconditioned pacemakers are as safe and effective as new ones after 90 days, suggesting a cost-effective alternative for low- and middle-income countries.
Racial Disparities in Clinical Trials: African Americans Severely Underrepresented in Multiple Myeloma Research
Despite African Americans comprising 20% of multiple myeloma patients in the US, they represent only 6% of clinical trial participants, highlighting a significant disparity in medical research.